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line carried a compound heterozygous mutation, c.896GNA(p.Arg299His) and c.929_930insC(p.Pro310Glnfs*9), of
TYR gene. Characteristic tests proved that the chHES-478 cell line presented typicalmarkers of pluripotency andhad
the capability to form the three germ layers both in vitro and in vivo.
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Human embryonic stem cell (hESC) line chHES-478 was derived
from abnormal blastocyst donated by a couple of albinism carriers
after preimplantation genetic diagnosis (PGD) treatment. DNA se-
quence analysis conﬁrmed a compound heterozygous mutation,
c.896GNA(p.Arg299His) and c.929_930insC(p.Pro310Glnfs*9), of
TYR gene in the cells. The missense mutation, c.896GN
A(p.Arg299His) caused a substitution at amino acid 299. This mu-
tation was already documented in the main databases such as
HGMD (http://www.hgmd.cf.ac.uk/ac/search.php) and ClinVar
(http://www.ncbi.nlm.nih.gov/clinvar), indicating a pathogenic
effect of this nucleotide change. The small insertion mutation,
c.929_930insC(p.Pro310Glnfs*9), may cause a frameshift at amino
acid 310 resulting in early termination of translation after 9
amino acid residues, indicating the pathogenic effect of this muta-
tion (Fig. 1A). The chHES-478 cells displayed pluripotent cell mor-
phology (Fig. 1B), and expressed pluripotency related genes such
as POU5F1, NANOG, SOX2, KLF4, TERF1 and THY1 (Fig. 1C). The
chHES-478 cells were also positive for pluripotent markers includ-
ing OCT4, NANOG, TRA-1-60 and TRA-1-81 as well as alkaline
phosphatise (Fig. 1D) and showed a stable Karyotype of 46, XX dur-
ing prolonged culture by the karyotype analysis (Fig. 1E). The
chHES-478 cells had the capability to differentiate into the deriva-
tives from all the three germ layers both in vitro (Fig. 1F) and in
vivo (Fig. 1G).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of chHES-478 cells. (A) A compound heterozygousmutation, c.896GNA (Arg299His) and c.929_930insC (Pro310Glnfs*9), of TYR genewas identiﬁed in chHES-478
cells; (B) Cells showed typical round shape colonies on the feeder layer of MEF; (C) Pluripotent genes detected by RT-PCR were expressed in chHES-478 cells including POU5F1, NANOG,
SOX2, KLF4, TERF1 and THY1; (D) Undifferentiated Colonies were positive for the pluripotency markers of OCT4, NANOG, TRA-1-60, TRA-1-81 and AKP. Nuclei staining with DAPI were in
the lower right corner. Scale bar = 100 μm; (E) chHES-478 has a normal karyotype 46, XX; (F) Derivatives from embryoid bodies of chHES-478 cells could differentiate into ectoderm
(TUJ1), mesoderm (SMA) and endoderm (AFP) in vitro. Scale bar = 50 μm; (G) Histological sections of teratomas formed by the chHES-478 cell line contain tissues derived from three
germ layers. Scale bar = 50 μm.
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2.1. Source of embryo
This study was approved and guided by the local ethical committee
of Reproductive and Genetic Hospital of CITIC-Xiangya. Abnormal em-
bryos with aberrantmutant of TYR genewere donated by a couple of al-
binism carriers after signed informed consent. These embryos werecultured in G-series sequential medium (G1 and G2, Vitrolife) to the
blastocyst stage at 37 °C in 5% CO2, 5%O2 and 90%N2with 95% humidity.
2.2. hESC line derivation and cell culture
The chHES-478 cells were established in our laboratory as previously
described (Lin et al., 2009). Brieﬂy, the inner cellmasswasmechanically
isolated and was plated on the mouse embryonic ﬁbroblast (MEF)
645Y. Sun et al. / Stem Cell Research 17 (2016) 643–645feeders. The cellswere cultured in serum-free DFSRmedium, containing
knock-out DMEM/F12medium supplementedwith 15% serum replace-
ment, 0.1 mM β-mercaptoethanol, 1% nonessential amino acids, 2 mM
L-glutamine, and 4 ng/ml human recombinant basic ﬁbroblast growth
factor (bFGF) (all from Invitrogen). Once the embryo outgrowth was
observed, it was transmitted onto fresh feeders and obtained the
hESC-colony morphology during prolonged culture. HESC colonies
were passaged mechanically per week for long-term culture.
2.3. PCR-Sanger sequencing
Genomic DNA was prepared with QIAmp® DNA mini kit (QIAGEN)
according to the manufacturer's instructions. Mutation of TYR gene
was examined by PCR ampliﬁcation. The following primers were used
for PCR ampliﬁcation reaction: 5′-CATGATTGTAGTAATCTCCTCAG-3′
and5′-GGGTCATTGTCGATATAACTATA-3′. PCR was performed using
50 μl PCR ampliﬁcation reaction mixture containing 1.5 μl of 100 ng ge-
nomic DNA, 1 μl of 1.0 μM of each primer, 25 μl of 2 × GreenMaster Mix
(Promega) and 22.5 μl H2O. Cycling conditionswere as follows: 95 °C for
1.5 min followed by 35 cycles of ampliﬁcation (95 °C denaturation for
40 s, 58 °C annealing for 40 s, 72 °C elongation for 40 s) and a ﬁnal ex-
tension at 72 °C for 5 min. The products of PCR were determined by
Sanger sequencing by using a BigDye Terminator cycle sequencing kit
v3.1 and an ABI 3130XL Genetic Analyzer (Applied Biosystems).
2.4. RT-PCR
Total RNA was extracted with Trizol reagent (Invitrogen) and two
microgram of RNA was reverse-transcribed into ﬁrst-strand cDNA by
using Transcriptor First Strand cDNA Synthesis Kit (Roche). The cDNA
was submitted to RT-PCR using the primer pairs as described previously
(Xie et al., 2016). PCR reactions were performed with GoTaq polymer-
ase (Promega) on 0.2 μl of a reverse-transcription reaction mix in a
total reaction volume of 10 μl. The PCR reaction was carried out as fol-
lows: 95 °C for 2 min followed by 35 cycles of ampliﬁcation (95 °C for
30 s, 54–64 °C for 30 s and 72 °C for 30 s), and a ﬁnal extension at
72 °C for 5 min. PCR products were separated by electrophoresis on a
1.5% agarose gel, and images were taken on a UV transluminator.
2.5. Immunocytochemical staining and alkaline phosphatase staining
ChHES-478 cells were harvested and ﬁxed in 4% paraformaldehyde
(PFA) for 20 min, and then blocked with 10% donkey serum in PBS for
30min and incubated with primary antibodies overnight at 4 °C. For in-
tracellular antigen, cells were blocked and permeabilized with PBS con-
taining 0.2% Triton X-100 (Sigma) and 10% donkey serum (Jackson
Immuno Research) for 30 min at room temperature. The following pri-
mary antibodies were used: mouse anti-OCT4 (1:200, Santa Cruz Bio-
technology), rabbit anti-NANOG (1:100, Abcam), mouse anti-TRA-1-
60 (1:50, Millipore), mouse anti-TRA-1-81 (1:50, Millipore), mouse
anti-β-tubulin (1:800, Sigma), mouse anti-AFP (1:500, Sigma), and
mouse anti-SMA (1:100, Millipore),overnight at 4 °C. Next, the cells
were stained with Alexa Fluor® 488 donkey anti-mouse lgG (1:1000,
Life Technologies) or Alexa Fluor® 488 donkey anti-rabbit lgG
(1:1000, Life Technologies) for 1 h at room temperature in the dark. Nu-
clei were then counterstained with 4′, 6-diamidino-2-phenylindole
(DAPI, 1:1000, Sigma). In addition, alkaline phosphatase activity was
detected according to the protocol of the BCIP/NBT Kit (Invitrogen). Im-
ages were acquired in an epiﬂuorescence microscopy (Nikon Eclipse
TE2000-U).2.6. Karyotyping analysis
ChHES-478 cells were cultured in mTeSR™1 medium (STEMCELL)
for 3-5 days, and then treated with 0.1μg/mL of KaryoMAX® Colcemid
™ solution (Life Technologies) for 3 h. After washing with PBS for
three times, the cells were dissociated with Accutase (Millipore) into
single cells and harvested using standard procedures, followed by stan-
dard G-banding for karyotyping. At least 20 metaphase spreads were
examined for each sample using an Olympus epi-ﬂuorescence micro-
scope BX51 (Olympus, Tokyo, Japan) with LUCIA KARYOTYPE software
(Lucia, Praha, Czech Republic).
2.7. In vitro and in vivo differentiation assay
For spontaneous in vitro differentiation assay, hESCs were mechani-
cally dissociated into small clumps and cultured as aggregates in sus-
pension for 7 days to form embryoid bodies (EBs) in DFSR medium
without bFGF. Then EBs were transmitted onto Matrigel (BD) coated
4-well plates for another 14-day culture. The derivatives of embryoid
bodies were processed for immunocytochemical staining analysis with
three germ layer marker (Ectoderm: TUJ1; mesoderm: SMA; endo-
derm: AFP).
For in vivo differentiation assay, 1 × 106 hESC cells were injected in-
tramuscularly into the right hind limb of 6 to 8-week-old mice with se-
vere combined immunodeﬁciency disease (SCID) mouse. After
10 weeks, teratoma was harvested and ﬁxed with 4% paraformalde-
hyde. To identify the derivatives from three germ layers, hematoxylin
and eosin (H&E) staining was carried out for the histological analysis.
Animal work was carried out in the animal facility of Xiangya School
of Medicine, Central South University in accordance with institutional
guidelines.
3. Veriﬁcation and authentication
Karyotyping and Sequencing analyses were performed at Reproduc-
tive & Genetic Hospital of CITIC-Xiangya. Twenty metaphase cells were
observed and all had a normal karyotype of 46, XX. After locus speciﬁc
PCR, Sanger sequencing analysis conﬁrmed a compound heterozygous
mutation, c.896GNA(p.Arg299His) and c.929_930insC(p.Pro310Glnfs*9),
of TYR gene in chHES-478 cells.
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